# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-19-306821
Filing Date
2019-12-05
Accepted
2019-12-05 08:31:16
Documents
44
Period of Report
2019-12-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d816321d8k.htm | 8-K | 18026
2 | EX-99.1 | d816321dex991.htm | EX-99.1 | 46781
3 | GRAPHIC | g816321ex99_1s10g1.jpg | GRAPHIC | 296816
4 | GRAPHIC | g816321ex99_1s11g1.jpg | GRAPHIC | 339244
5 | GRAPHIC | g816321ex99_1s12g1.jpg | GRAPHIC | 285484
6 | GRAPHIC | g816321ex99_1s13g1.jpg | GRAPHIC | 282452
7 | GRAPHIC | g816321ex99_1s14g1.jpg | GRAPHIC | 330007
8 | GRAPHIC | g816321ex99_1s15g1.jpg | GRAPHIC | 292427
9 | GRAPHIC | g816321ex99_1s16g1.jpg | GRAPHIC | 310716
10 | GRAPHIC | g816321ex99_1s17g1.jpg | GRAPHIC | 301954
11 | GRAPHIC | g816321ex99_1s18g1.jpg | GRAPHIC | 322289
12 | GRAPHIC | g816321ex99_1s19g1.jpg | GRAPHIC | 315846
13 | GRAPHIC | g816321ex99_1s1g1.jpg | GRAPHIC | 213990
14 | GRAPHIC | g816321ex99_1s20g1.jpg | GRAPHIC | 258969
15 | GRAPHIC | g816321ex99_1s21g1.jpg | GRAPHIC | 251153
16 | GRAPHIC | g816321ex99_1s22g1.jpg | GRAPHIC | 260054
17 | GRAPHIC | g816321ex99_1s23g1.jpg | GRAPHIC | 320790
18 | GRAPHIC | g816321ex99_1s24g1.jpg | GRAPHIC | 351195
19 | GRAPHIC | g816321ex99_1s25g1.jpg | GRAPHIC | 357390
20 | GRAPHIC | g816321ex99_1s26g1.jpg | GRAPHIC | 230158
21 | GRAPHIC | g816321ex99_1s27g1.jpg | GRAPHIC | 237869
22 | GRAPHIC | g816321ex99_1s28g1.jpg | GRAPHIC | 310854
23 | GRAPHIC | g816321ex99_1s29g1.jpg | GRAPHIC | 244964
24 | GRAPHIC | g816321ex99_1s2g1.jpg | GRAPHIC | 494925
25 | GRAPHIC | g816321ex99_1s30g1.jpg | GRAPHIC | 287023
26 | GRAPHIC | g816321ex99_1s31g1.jpg | GRAPHIC | 247035
27 | GRAPHIC | g816321ex99_1s32g1.jpg | GRAPHIC | 317882
28 | GRAPHIC | g816321ex99_1s33g1.jpg | GRAPHIC | 293996
29 | GRAPHIC | g816321ex99_1s34g1.jpg | GRAPHIC | 265280
30 | GRAPHIC | g816321ex99_1s35g1.jpg | GRAPHIC | 201960
31 | GRAPHIC | g816321ex99_1s36g1.jpg | GRAPHIC | 314320
32 | GRAPHIC | g816321ex99_1s37g1.jpg | GRAPHIC | 279016
33 | GRAPHIC | g816321ex99_1s38g1.jpg | GRAPHIC | 322109
34 | GRAPHIC | g816321ex99_1s39g1.jpg | GRAPHIC | 256671
35 | GRAPHIC | g816321ex99_1s3g1.jpg | GRAPHIC | 292697
36 | GRAPHIC | g816321ex99_1s40g1.jpg | GRAPHIC | 273309
37 | GRAPHIC | g816321ex99_1s41g1.jpg | GRAPHIC | 329953
38 | GRAPHIC | g816321ex99_1s42g1.jpg | GRAPHIC | 235215
39 | GRAPHIC | g816321ex99_1s4g1.jpg | GRAPHIC | 355399
40 | GRAPHIC | g816321ex99_1s5g1.jpg | GRAPHIC | 284346
41 | GRAPHIC | g816321ex99_1s6g1.jpg | GRAPHIC | 297237
42 | GRAPHIC | g816321ex99_1s7g1.jpg | GRAPHIC | 355478
43 | GRAPHIC | g816321ex99_1s8g1.jpg | GRAPHIC | 294743
44 | GRAPHIC | g816321ex99_1s9g1.jpg | GRAPHIC | 265696
| Complete submission text file | 0001193125-19-306821.txt |  | 17121131

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38266 | Film No.: 191269513
SIC: 2834 Pharmaceutical Preparations